FIELD: chemistry.
SUBSTANCE: present invention relates to organic synthesis of magnetic materials, specifically to 5-(benzo[d]thiazol-2-yl)-6-methyl-1-(4-methoxyphenyl)-3-(2-pyridyl)-verdazyl of formula I. Invention also relates to a method of producing said compound.
EFFECT: creation of a new compound capable of acting as a component of magnetoactive organometallic complexes, as well as development of a method for its preparation with high output.
2 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-[5-(4-METHOXY)-3-PHENYL-5,6-DIHYDRO-4H-[1,2,4,5]TETRAZIN-1-YL]-BENZOTHIAZOLES WITH ANTIVIRAL ACTIVITY AGAINST COXSACKIE B3 VIRUSES | 2022 |
|
RU2783659C1 |
| ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
| BIS[1,2,4]TRIAZOLO[4,3-b:3',4'-f][1,2,4,5]TETRAZINES WITH ANTI-GLYCATING, ANTI-GLYCOXIDATION AND ANTIPLATELET ACTIVITY | 2020 |
|
RU2755897C1 |
| 4-ISOPROPYL-6-R-IMIDAZO[1,2-B][1,2,4,5]TETRAZIN-3(4H)- ES WITH ANTIBACTERIAL ACTIVITY AGAINST NEISSERIA GONORRHOEAE | 2020 |
|
RU2754554C1 |
| ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE | 2013 |
|
RU2545458C2 |
| HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
| DERIVATIVES OF THIAZOLE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2218337C2 |
| TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
| DERIVATIVES OF 2-ACYLAMINO-4-PHENYLTHIAZOL, THEIR OBTAINMENT AND APPLICATION IN THERAPY | 2004 |
|
RU2348630C2 |
| POLYCYCLIC THIAZOLIDINE-2-YLIDENE AMINES, MEDICINAL AGENTS CONTAINING THEREOF AND METHOD FOR PREPARING MEDICINAL AGENT | 1999 |
|
RU2236405C2 |
